Bicara Therapeutics BCAX Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Bicara Therapeutics’s reported figures.
The official record: Bicara Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bicara Therapeutics's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bicara Therapeutics's free cash flow?
- Bicara Therapeutics (BCAX) reported free cash flow of -$37.57M in Q1 2026.
- How has Bicara Therapeutics's free cash flow changed year-over-year?
- Bicara Therapeutics's free cash flow decreased by 33.7% year-over-year, from -$28.11M to -$37.57M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.